BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

504 related articles for article (PubMed ID: 21752594)

  • 1. Antiepileptic drugs with mood stabilizing properties and their relation with psychotropic drug use in institutionalized epilepsy patients with intellectual disability.
    Leunissen CL; de la Parra NM; Tan IY; Rentmeester TW; Vader CI; Veendrick-Meekes MJ; Aldenkamp AP
    Res Dev Disabil; 2011; 32(6):2660-8. PubMed ID: 21752594
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of antiepileptic drugs in the treatment of epilepsy in people with intellectual disability.
    Alvarez N; Besag F; Iivanainen M
    J Intellect Disabil Res; 1998 Dec; 42 Suppl 1():1-15. PubMed ID: 10030426
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Antiepileptic drugs as mood stabilizers: what did we learn from the epileptology?].
    Rajna P
    Ideggyogy Sz; 2008 Sep; 61(9-10):305-16. PubMed ID: 18841650
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and tolerability of adjunctive lamotrigine for refractory epilepsy in institutional or community residents with mental retardation.
    Sunder TR; McKee JR; Hammer AE; Vuongc A
    Curr Med Res Opin; 2006 Apr; 22(4):693-702. PubMed ID: 16684430
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lamotrigine in the treatment of epilepsy in people with intellectual disability.
    Besag FM
    J Intellect Disabil Res; 1998 Dec; 42 Suppl 1():50-6. PubMed ID: 10030433
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term course of epilepsy in a large cohort of intellectually disabled patients.
    Huber B; Hauser I; Horstmann V; Jokeit G; Liem S; May T; Meinert T; Robertson E; Schorlemmer H; Wagner W; Seidel M
    Seizure; 2007 Jan; 16(1):35-42. PubMed ID: 17157535
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence and patterns of anti-epileptic medication prescribing in the treatment of epilepsy in older adults with intellectual disabilities.
    O'Dwyer M; Peklar J; Mulryan N; McCallion P; McCarron M; Henman MC
    J Intellect Disabil Res; 2018 Mar; 62(3):245-261. PubMed ID: 29314463
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Psychiatric comedication in patients with epilepsy.
    Bosak M; Cyranka K; Dudek D; Kowalik M; Mołek P; Słowik A
    Epilepsy Behav; 2018 Jun; 83():207-211. PubMed ID: 29706306
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of age, weight and concomitant treatment on lamotrigine pharmacokinetics.
    Brzaković BB; Vezmar Kovačević SD; Vučićević KM; Miljković BR; Martinović ZJ; Pokrajac MV; Prostran MŠ
    J Clin Pharm Ther; 2012 Dec; 37(6):693-7. PubMed ID: 22583007
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Various matters concerning the improvement of therapeutic tactics in epilepsy].
    Vaĭntrub MIa
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1986; 86(6):858-62. PubMed ID: 3092518
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evolving antiepileptic drug treatment in juvenile myoclonic epilepsy.
    Prasad A; Kuzniecky RI; Knowlton RC; Welty TE; Martin RC; Mendez M; Faught RE
    Arch Neurol; 2003 Aug; 60(8):1100-5. PubMed ID: 12925366
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Psychotropic effects of antiepileptic drugs.
    Ettinger AB
    Neurology; 2006 Dec; 67(11):1916-25. PubMed ID: 17159095
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characteristics and the trajectory of psychotropic medication use in general and antipsychotics in particular among adults with an intellectual disability who exhibit aggressive behaviour.
    Deb S; Unwin G; Deb T
    J Intellect Disabil Res; 2015 Jan; 59(1):11-25. PubMed ID: 24450426
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of long-term antiepileptic drug monotherapy on vascular risk factors and atherosclerosis.
    Chuang YC; Chuang HY; Lin TK; Chang CC; Lu CH; Chang WN; Chen SD; Tan TY; Huang CR; Chan SH
    Epilepsia; 2012 Jan; 53(1):120-8. PubMed ID: 22085257
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiepileptic drugs and mood stability.
    Amann B; Grunze H; Vieta E; Trimble M
    Clin EEG Neurosci; 2007 Apr; 38(2):116-23. PubMed ID: 17515177
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patterns of lamotrigine use in daily clinical practice during the first 5 years after introduction in the Netherlands.
    Knoester PD; Belitser SV; Deckers CL; Keyser A; Renier WO; Egberts AC; Hekster YA
    J Clin Pharm Ther; 2004 Apr; 29(2):131-8. PubMed ID: 15068401
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lamotrigine in epilepsy, pregnancy and psychiatry--a drug for all seasons?
    Vajda FJ; Dodd S; Horgan D
    J Clin Neurosci; 2013 Jan; 20(1):13-6. PubMed ID: 23036173
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adjunctive lamotrigine for refractory epilepsy in adolescents with mental retardation.
    McKee JR; Sunder TR; Vuong A; Hammer AE
    J Child Neurol; 2006 May; 21(5):372-9. PubMed ID: 16901441
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of antiepileptic drug comedication on lamotrigine concentrations.
    Lovrić M; Čajić I; Petelin Gadže Ž; Klarica Domjanović I; Božina N
    Croat Med J; 2018 Feb; 59(1):13-19. PubMed ID: 29498493
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oxcarbazepine in the treatment of epilepsy in children and adolescents with intellectual disability.
    Gaily E; Granström ML; Liukkonen E
    J Intellect Disabil Res; 1998 Dec; 42 Suppl 1():41-5. PubMed ID: 10030431
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.